Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | GM-CSF | 361.5 | 76 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | GM-CSF | 434.5 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GM-CSF | 475.0 | 66 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | GM-CSF | 466.5 | 52 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GM-CSF | 422.0 | 52 | |
N2645 | TNF-a | 100 | ng/mL | 2 | GM-CSF | 456.0 | 84 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GM-CSF | 481.0 | 59 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | GM-CSF | 470.0 | 59 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 281.5 | 80 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 292.0 | 87 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 283.0 | 75 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 343.5 | 76 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 297.5 | 60 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 361.0 | 70 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 451.0 | 58 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 411.0 | 81 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 397.5 | 74 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 403.0 | 60 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 448.5 | 52 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | GM-CSF | 492.0 | 52 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 267.5 | 68 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 307.0 | 75 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 283.0 | 81 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 307.5 | 76 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 288.0 | 71 |